师资

EN       返回上一级       师资搜索
胡坚杨
研究助理教授
hujy@sustech.edu.cn

个人简介:

胡坚杨博士,南方科技大学医学院生物化学系研究助理教授,副研究员。于2020年博士毕业于香港城市大学,期间主要研究1)三阴性乳腺癌(TNBC)特异性超级增强子对关键转录因子的调控;2)TCOF1蛋白调控三阴性乳腺癌的细胞干性。于香港城市大学进行博士后训练期间研究外泌体对三阴性乳腺癌转移的影响。2021年7月加入南方科技大学医学院洪鑫课题组,主要利用循环肿瘤细胞等模型研究肿瘤细胞的衰老、转移。研究的总体目标是为肿瘤的治疗提供潜在的药物靶点。目前已在 Nature communication,British Journal of Cancer,Biochemical Pharmacology等期刊发表13篇科技论文,总引用大于480,H-index为10。申请中国专利3项,美国专利2项。获国家自然科学基金青年项目,深圳市科创委-优秀科技创新人才培养项目(青年项目),中国博士后面上项目以及广东省海外博士后人才支持项目资助。

 

教育背景:

2017.09-2020.10 博士,生物医学,香港城市大学

2012.09-2015.06 硕士,药理学,  暨南大学

2008.09-2012.06 学士,药学,    广州中医药大学

 

工作经历:

2023.08-今       研究助理教授,南方科技大学 医学院

2021.07-2023.07  博士后,      南方科技大学 医学院

2020.10-2021.06  博士后,      香港城市大学 生物医学系

2017.02-2017.08  研究助理,    香港城市大学 生物医学系

 

研究领域:

1)肿瘤细胞衰老调控

2)肿瘤转移机制

3)肿瘤微环境中细胞间通讯,如外泌体介导的细胞间通讯

 

发表论文:

1. Huang H#, Hu JY#, Maryam A, Huang QH, Zhang YC, Ramakrishnan S, Li JY, Ma HY, Ma V, Cheuk W, So G, Wang W, Cho W, Zhang L, Chan KM, Wang X* & Chin YR*. Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling. Nature communications, 2021, 12:2242. (Co-first author, IF:17.694).

2. Hu JY, Lai Y, Huang H, Ramakrishnan S, Pan Y, Ma VW, Cheuk W, So GY, He Q, Lau CG, Zhang L, Cho WC, Chan KM, Wang X, Chin YR. TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumor growth, and correlates with poor prognosis. British Journal of Cancer, 2022, 126:57-71. IF:9.08.

3. Sun HY#, Ou T#, Hu JY#, Yang ZY, Lei QF, Li YQ, Wang G, Li YP, Wu K, Wang SP, Wu S. Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancer. Biochemical Pharmacology, 2021, 190:114588. (# Co-first author, IF:6.1)

4. Zhuo ZZ#, Hu JY#, Chen MF, Lei XP, Deng LJ, Yao N, Peng QL, Chen ZS, Ye WC *, Zhang DM*. Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo. Scientific reports, 2015, 5: 16185. (# Co-first author, IF: 4.997)

5. Zhou M, Li WP, Li J, Xie LM, Wu RB, Wang L, Fu S, Su W, Hu JY, Li PL. Phase-separated condensate-aided enrichment of biomolecular interactions for high-throughput drug screening in test tubes. Journal of Biological Chemistry, 2020, 295(33): 11420-11434.

6. Liu JS., Huo CY, Cao HH, Fan CL, Hu JY, Deng LJ, ... Yu ZL. (2019). Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Phytomedicine, 2019, 61: 152843.

7. Sun HY, Huang MH, Yao N, HU JY, Li YJ, Chen LP, HU N, Ye WC, Tai WillamChi-Shing, Zhang DM, Chen SB. The cycloartane triterpenoid ADCX impairs autophagic degradation through Akt overactivation and promotes apoptotic cell death in multidrug-resistant HepG2/ADM cells. Biochemical Pharmacology, 2017, 146: 87-100.

8. Chen LP, Mai WQ, Chen MF, Hu JY, Zhuo ZZ, Lei XP, Deng LJ, Liu JS, Yao N, Huang MH, Peng YH, Ye WC, Zhang D. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin. Pharmacological research, 2017, 123: 130-142.

9. Chen MF, Lei XP, Shi CZ, Huang MH, Wu BJ, Li ZQ, Han WL, Du B, Hu JY, Nie QL, Mai WQ, Ma N, Xu NH, Zhang XY, Xia MH, Luo LP, Ma Ande, Li HS, Yu Q, Chen HRR, Zhang DM, Ye WC. Targeting tumor pericytes with a FAP-alpha-activated prodrug combats tumor resistance to vascular disrupting agents. Journal of Clinical Investigation, 2017, 127(10): 3689–3701.

10. Lei XP, Chen MF, Nie QL, Hu JY, Zhuo ZJ, Yiu A, Chen HR, Xu NH, Bai LL, Zhang DM*, Ye WC*. In vitro and in vivo antiangiogenic activity of desacetylvinblastine monohydrazide through inhibition of VEGFR2 and Axl pathways. American Journal of Cancer Research, 2016, 6(4):843-858. 

11. Sun HY, Liu BB, Hu JY, Yang XL, Xu LJ, Chan SW, Chan CO, Daniel K.W. Mok, Zhang DM*, Ye WC*, Chen SB*. New cycloartane triterpenoid from Cimicifuga foetida induces mitochondrial apoptosis in human breast carcinoma MCF-7 cells via inhibiting Raf/MEK/ERK pathway and Akt phosphorylation. Chinese Medicine, 2016, 11(1): 1-11.

12. Zhang W, Huang XJ, Zhang SY, Zhang DM, Jiang RW, Hu JY, Zhang XQ, Wang L*, Ye WC*.  Geleganidines A–C, Unusual Monoterpenoid Indole Alkaloids from Gelsemium elegans. Journal of natural products, 2015, 78(8): 2036-2044.

13. Hu JY, Chen MF, Lei XP, Zhuo ZJ, Sun HY, Chen ZS, Shi Z, Zhang DM*, Ye WC*. Bufalin induces apoptosis of MDA-MB-231 cell through activation of JNK/p53 pathway. Journal of Cancer Research Updates, 2015, 4(2): 47-53.